Cited by 17Thyroid Disorders and TreatmentsClinical Laboratory Practices and Quality ControlAdrenal Hormones and Disorders

Assessment of thyroid function in intensive care unit patients by liquid chromatography tandem mass spectrometry methods

Open access
Welsh, Kerry J., Stolze, Brian R., Yu, Xiaolin, Podsiadlo, Trisha R., Kim, Lisa S., Soldin, Steven J.·2017·Clinical Biochemistry

Abstract

Objectives Patients with non-thyroidal illness syndrome have many abnormalities in thyroid hormone tests. Such patients have medical comorbidities associated with low serum proteins and are on multiple medications that interfere with thyroid hormone measurement by immunoassay platforms. It is unknown if these thyroid hormone measurements reflect physiologic conditions or if they are artifacts of testing methodology. Methods Fifty patients were selected from the intensive care unit (ICU) from our institution. Total and free thyroid hormones in plasma were measured by gold standard liquid chromatography-tandem mass spectrometry (LC-MSMS). The results were compared to the Roche Cobas 6000. Patient medical comorbidities and binding protein levels were assessed. Results Concentrations of total 3,5,5'-triidothyronine (TT3) and total thyroxine (TT4) were significantly more likely to be low by LC-MSMS compared to immunoassay. Free 3,5,5'-triidothyronine (FT3) levels were similar by immunoassay and LC-MSMS. However, FT4 concentrations were mildly elevated for many patients when measured by ultrafiltration LC-MSMS (19/50, 38%) compared to 1/50 (2%) when measured by immunoassay (p=0.0001). Decreased albumin and thyroxine binding globulin were common and patients were on an average of 11.7±5.0 medications, all factors known to interfere with results found on immunoassays. Conclusions Marked discrepancies in thyroid hormone measurement were noted between reference LC-MSMS and a common immunoassay platform. It is hypothesized that T4 binding to low affinity albumin is displaced by several drugs, raising concentrations of FT4 by LC-MSMS compared to immunoassay, and that the immunoassay values are falsely decreased due to low binding proteins in our patient population.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.clinbiochem.2016.11.022

Cites

3 of 3 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Several laboratories have developed procedures to accurately determine total T4 and total T3 in human plasma or serum and largely agree on concentration ranges, but this consensus has not been achieved for most other TH metabolites.

    “While meanwhile several laboratories developed procedures to accurately determine total T4 and total T3 in human plasma or serum and largely agree on concentrations ranges (25, 67–73), this consensus has not been achieved yet for most of the other TH metabolites, which occur at much lower concentrations.”

    From 3,5-T2—A Janus-Faced Thyroid Hormone Metabolite Exerts Both Canonical T3-Mimetic Endocrine and Intracrine Hepatic Action (2020) · cites this paper as [67]

    The Methods (Laboratory methods; page unavailable) describe a validated LC-MSMS procedure for measuring total T3 and T4 in human plasma and give reference intervals. The paper does not establish agreement on concentration ranges across laboratories or address whether a consensus exists for most other thyroid hormone metabolites. (LLM, conf=0.84)

    Experimental — accuracy not yet measured

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 28

  1. [1]Adler SM Wartofsky L The nonthyroidal illness syndrome Endocrinol Metab Clin North Am 2007 36 657 672 vi 17673123
  2. [2]Farwell AP Nonthyroidal illness syndrome Curr Opin Endocrinol Diabetes Obes 2013 20 478 484 23974778
  3. [4]van Deventer HE Soldin SJ The expanding role of tandem mass spectrometry in optimizing diagnosis and treatment of thyroid disease Adv Clin Chem 2013 61 127 152 24015601
  4. [5]Welsh KJ Soldin SJ How reliable are free thyroid and total T3 hormone assays? Euro J Endocrin 2016 175 R255 R263 PMC5113291 27737898
  5. [7]van Deventer HE Mendu DR Remaley AT Soldin SJ Inverse log-linear relationship between thyroid-stimulating hormone and free thyroxine measured by direct analog immunoassay and tandem mass spectrometry Clin Chem 2011 57 122 127 21097676
  6. [8]Gounden V Jonklaas J Soldin SJ A pilot study: subclinical hypothyroidism and free thyroid hormone measurement by immunoassay and mass spectrometry Clin Chim Acta 2014 430 121 124 24389098 PMC3971640
  7. [9]Csako G Zweig MH Benson C Ruddel M On the albumin-dependence of measurements of free thyroxin. II. Patients with non-thyroidal illness Clin Chem 1987 33 87 92 3100099
  8. [10]Iitaka M Kawasaki S Sakurai S Hara Y Kuriyama R Yamanaka K Kitahama S Miura S Kawakami Y Katayama S Serum substances that interfere with thyroid hormone assays in patients with chronic renal failure Clin Endocrinol (Oxf) 1998 48 739 746 9713563
  9. [11]Lim CF Bai Y Topliss DJ Barlow JW Stockigt JR Drug and fatty acid effects on serum thyroid hormone binding J Clin Endocrinol Metab 1988 67 682 688 3417847
  10. [12]Stevenson HP Archbold GP Johnston P Young IS Sheridan B Misleading serum free thyroxine results during low molecular weight heparin treatment Clin Chem 1998 44 1002 1007 9590373
  11. [13]Surks MI DeFesi CR Normal serum free thyroid hormone concentrations in patients treated with phenytoin or carbamazepine. A paradox resolved JAMA 1996 275 1495 1498 8622224
  12. [14]Gu J Soldin OP Soldin SJ Simultaneous quantification of free triiodothyronine and free thyroxine by isotope dilution tandem mass spectrometry Clin Biochem 2007 40 1386 1391 17936741
  13. [16]Jonklaas J Sathasivam A Wang H Gu J Burman KD Soldin SJ Total and free thyroxine and triiodothyronine: measurement discrepancies, particularly in inpatients Clin Biochem 2014 47 1272 1278 24936679 PMC4187214
  14. [18]Chopra IJ Taing P Mikus L Direct determination of free triiodothyronine (T3) in undiluted serum by equilibrium dialysis/radioimmunoassay (RIA) Thyroid 1996 6 255 259 8875743
  15. [20]Plikat K Langgartner J Buettner R Bollheimer LC Woenckhaus U Scholmerich J Wrede CE Frequency and outcome of patients with nonthyroidal illness syndrome in a medical intensive care unit Metabolism 2007 56 239 244 17224339
  16. [21]Sapin R Schlienger JL Kaltenbach G Gasser F Christofides N Roul G Gervais A Petitjean P Chambron J Determination of free triiodothyronine by six different methods in patients with non-thyroidal illness and in patients treated with amiodarone Ann Clin Biochem 1995 32 Pt 3 314 324 7632037
  17. [22]Surks MI Hupart KH Pan C Shapiro LE Normal free thyroxine in critical nonthyroidal illnesses measured by ultrafiltration of undiluted serum and equilibrium dialysis J Clin Endocrinol Metab 1988 67 1031 1039 3182956
  18. [23]Masika LS Zhao Z Soldin SJ Is measurement of TT3 by immunoassay reliable at low concentrations? A comparison of the Roche Cobas 6000 vs. LC-MSMS Clin Biochem 2016 49 846 849 26879528 PMC4972640
  19. [24]Chopra IJ Simultaneous measurement of free thyroxine and free 3,5,3'-triiodothyronine in undiluted serum by direct equilibrium dialysis/radioimmunoassay: evidence that free triiodothyronine and free thyroxine are normal in many patients with the low triiodothyronine syndrome Thyroid 1998 8 249 257 9545112
  20. [25]Faber J Kirkegaard C Rasmussen B Westh H Busch-Sorensen M Jensen IW Pituitary-thyroid axis in critical illness J Clin Endocrinol Metab 1987 65 315 320 3597710
  21. [26]Chopra IJ Solomon DH Hepner GW Morgenstein AA Misleadingly low free thyroxine index and usefulness of reverse triiodothyronine measurement in nonthyroidal illnesses Ann Intern Med 1979 90 905 912 443685
  22. [27]Kaptein EM MacIntyre SS Weiner JM Spencer CA Nicoloff JT Free thyroxine estimates in nonthyroidal illness: comparison of eight methods J Clin Endocrinol Metab 1981 52 1073 1077 6164687
  23. [28]Melmed S Geola FL Reed AW Pekary AE Park J Hershman JM A comparison of methods for assessing thyroid function in nonthyroidal illness J Clin Endocrinol Metab 1982 54 300 306 6172442
  24. [29]Nelson JC Weiss RM The effect of serum dilution on free thyroxine (T4) concentration in the low T4 syndrome of nonthyroidal illness J Clin Endocrinol Metab 1985 61 239 246 3924947
  25. [30]Wang R Nelson JC Weiss RM Wilcox RB Accuracy of free thyroxine measurements across natural ranges of thyroxine binding to serum proteins Thyroid 2000 10 31 39 10691311
  26. [31]Burmeister LA Reverse T3 does not reliably differentiate hypothyroid sick syndrome from euthyroid sick syndrome Thyroid 1995 5 435 441 8808092
  27. [32]Peeters RP Wouters PJ Kaptein E van Toor H Visser TJ Van den Berghe G Reduced activation and increased inactivation of thyroid hormone in tissues of critically ill patients J Clin Endocrinol Metab 2003 88 3202 3211 12843166
  28. [34]Kohrle J The selenoenzyme family of deiodinase isozymes controls local thyroid hormone availability Rev Endocr Metab Disord 2000 1 49 58 11704992

Cited by

Sorted by citations

Authors
Welsh, K. J., Stolze, B. R., Yu, X., Podsiadlo, T. R., Kim, L. S., & Soldin, S. J.
Affiliations
National Institutes of Health (US)
Corresponding author
Soldin, Steven J.
Venue
Clinical Biochemistry
Publisher
Elsevier BV
Published
2017-04
Volume
50
Issue
6
Pages
318-322
ISSN
0009-9120 (ISSN-L)
OpenAlex
W2552087489
Cited by
17
References
3
Citations by year
2025: 1 · 2024: 2 · 2023: 3 · 2022: 2 · 2021: 2 · 2020: 3 · 2019: 3 · 2017: 1
FWCI
1.13
Type
journal article
Language
en
Open access
Locations
  • Clinical Biochemistry (publishedVersion)
  • PubMed (publishedVersion)
  • PubMed Central (acceptedVersion)
Funders
  • National Institutes of Health
  • NIH Clinical Center (ZIACL010355)
Topics
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Thyroid Disorders and Treatments
  • Health Sciences › Medicine › Physiology › Clinical Laboratory Practices and Quality Control
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adrenal Hormones and Disorders
Keywords
thyroid function, low T3 syndrome, intensive care unit patients, thyroid hormone measurement, free thyroxine, total thyroxine, triiodothyronine, immunoassay interference, drug interference, thyroxine-binding globulin, binding proteins
MeSH terms
Adult, Aged, Chromatography, Liquid, Female, Humans, Immunoassay, Intensive Care Units, Male, Middle Aged, Thyroid Diseases, Thyroid Function Tests, Thyroid Gland, Thyroxine, Triiodothyronine, Biomarkers, Tandem Mass Spectrometry, Young Adult

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review